LKIM
TNDM icon

Lawson Kroeker Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

Lawson Kroeker Investment Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,500
Closed -$306K – 91
2024
Q4 		$306K Hold
8,500
– – 0.06% 86
2024
Q3 		$360K Hold
8,500
– – 0.07% 82
2024
Q2 		$342K Buy
+8,500
New +$355K 0.07% 84

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lawson Kroeker Investment Management's TNDM Position: Q1 2025 in Review

Lawson Kroeker Investment Management sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 8,500 shares — an estimated $306K sold.

Lawson Kroeker Investment Management first reported a position in TNDM in Q2 2024 and held it in 3 quarters. The position peaked at $360K in Q3 2024. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • Lawson Kroeker Investment Management reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • Lawson Kroeker Investment Management sold 8,500 Tandem Diabetes Care shares in Q1 2025, an estimated $306K.
  • Lawson Kroeker Investment Management first reported a position in Tandem Diabetes Care in Q2 2024 and held it in 3 quarters.
  • Lawson Kroeker Investment Management's Tandem Diabetes Care position peaked at $360K in Q3 2024.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Lawson Kroeker Investment Management's 13F filing for Q1 2025, filed 28 Apr 2025.